ProShares Trust (BIB)
Management Company · XNAS · Series S000018718 · View on SEC EDGAR ↗
$126.22
As of Aug. 19, 2026
▲ +14.24 (+12.71%)
1-day change
$54.56 – $126.40
52-week range
- Net assets
- $73.7M
- Holdings
- 267
- As of
- May 31, 2026
- Top 10 holdings weight
- 42.99%
- Effective number of positions
- 40.3
- Positions above 1%
- 20
On this page
- Price chart The fund's market price over time, with technical overlays.
- Performance Total return, volatility, drawdown and other risk metrics.
- Fund flows Money flowing in and out of the fund each month, from N-PORT filings.
- Holdings Every position the fund currently holds, with weights.
- Sector breakdown How the fund's holdings split across market sectors.
- Institutional owners 13F institutions that report holding this ETF.
- Similar funds Other funds with overlapping holdings or comparable size.
BIB Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
Performance as of March 10, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▲ +1.07% | — |
| 3M | ▲ +7.05% | — |
| 6M | ▲ +49.02% | — |
| YTD | ▲ +6.58% | — |
| 1Y | ▲ +57.26% | — |
| 3Y | — | — |
| 5Y | — | — |
| Max since Feb. 27, 2024 | ▲ +36.57% | — |
- Volatility 1Y
- 45.98%
- Volatility 3Y
- —
- Max drawdown 3Y
- —
- Beta 3Y
- —
- Sharpe 1Y*
- 1.23
Total return is shown once dividend history for this fund has been collected — price return alone would duplicate it misleadingly. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
- Last month (May 2026)
- -$4.8M
- Quarter ending May 2026
- -$13.9M
- Trailing 12 months
- -$12.0M
Jun 2025 – May 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 267 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| WaVe Life Sciences Ltd. | — | $46K | 0.06 | 6,960 | EC | SG |
| Compass Pathways plc | 20451W101 | $46K | 0.06 | 3,487 | EC | GB |
| Personalis, Inc. | 71535D106 | $44K | 0.06 | 3,869 | EC | US |
| MannKind Corp. | 56400P706 | $43K | 0.06 | 11,389 | EC | US |
| EyePoint, Inc. | 30233G209 | $42K | 0.06 | 3,062 | EC | US |
| Alvotech SA | — | $41K | 0.06 | 12,210 | EC | LU |
| Collegium Pharmaceutical, Inc. | 19459J104 | $39K | 0.05 | 1,172 | EC | US |
| Savara, Inc. | 805111101 | $39K | 0.05 | 7,524 | EC | US |
| Olema Pharmaceuticals, Inc. | 68062P106 | $39K | 0.05 | 2,962 | EC | US |
| Corvus Pharmaceuticals, Inc. | 221015100 | $38K | 0.05 | 3,054 | EC | US |
| Xeris Biopharma Holdings, Inc. | 98422E103 | $38K | 0.05 | 6,134 | EC | US |
| Absci Corp. | 00091E109 | $38K | 0.05 | 5,561 | EC | US |
| Zenas Biopharma, Inc. | 98937L105 | $36K | 0.05 | 1,983 | EC | US |
| Cullinan Therapeutics, Inc. | 230031106 | $36K | 0.05 | 2,185 | EC | US |
| Grifols SA | 398438408 | $35K | 0.05 | 4,510 | EC | ES |
| Pacira BioSciences, Inc. | 695127100 | $35K | 0.05 | 1,495 | EC | US |
| ARS Pharmaceuticals, Inc. | 82835W108 | $33K | 0.05 | 3,656 | EC | US |
| Janux Therapeutics, Inc. | 47103J105 | $33K | 0.04 | 2,251 | EC | US |
| Kura Oncology, Inc. | 50127T109 | $33K | 0.04 | 3,218 | EC | US |
| Sana Biotechnology, Inc. | 799566104 | $33K | 0.04 | 9,849 | EC | US |
| Arbutus Biopharma Corp. | 03879J100 | $32K | 0.04 | 7,110 | EC | CA |
| Xencor, Inc. | 98401F105 | $32K | 0.04 | 2,711 | EC | US |
| MeiraGTx Holdings plc | — | $32K | 0.04 | 2,975 | EC | KY |
| Amphastar Pharmaceuticals, Inc. | 03209R103 | $32K | 0.04 | 1,677 | EC | US |
| ORIC Pharmaceuticals, Inc. | 68622P109 | $31K | 0.04 | 3,711 | EC | US |
| Eton Pharmaceuticals, Inc. | 29772L108 | $30K | 0.04 | 992 | EC | US |
| Theravance Biopharma, Inc. | — | $30K | 0.04 | 1,875 | EC | KY |
| Mesoblast Ltd. | 590717401 | $30K | 0.04 | 1,934 | EC | AU |
| Geron Corp. | 374163103 | $30K | 0.04 | 23,602 | EC | US |
| Annexon, Inc. | 03589W102 | $29K | 0.04 | 5,349 | EC | US |
| Omeros Corp. | 682143102 | $29K | 0.04 | 2,622 | EC | US |
| Phathom Pharmaceuticals, Inc. | 71722W107 | $28K | 0.04 | 2,912 | EC | US |
| BioAge Labs, Inc. | 09077V100 | $28K | 0.04 | 1,604 | EC | US |
| Esperion Therapeutics, Inc. | 29664W105 | $28K | 0.04 | 8,837 | EC | US |
| Replimune Group, Inc. | 76029N106 | $27K | 0.04 | 3,053 | EC | US |
| Maravai LifeSciences Holdings, Inc. | 56600D107 | $26K | 0.04 | 5,410 | EC | US |
| CorMedix, Inc. | 21900C308 | $25K | 0.03 | 2,911 | EC | US |
| Zevra Therapeutics, Inc. | 488445206 | $24K | 0.03 | 2,083 | EC | US |
| Prime Medicine, Inc. | 74168J101 | $24K | 0.03 | 6,673 | EC | US |
| Phibro Animal Health Corp. | 71742Q106 | $23K | 0.03 | 763 | EC | US |
| Castle Biosciences, Inc. | 14843C105 | $23K | 0.03 | 1,100 | EC | US |
| Vor BioPharma, Inc. | 929033207 | $23K | 0.03 | 1,536 | EC | US |
| CytomX Therapeutics, Inc. | 23284F105 | $23K | 0.03 | 6,265 | EC | US |
| Candel Therapeutics, Inc. | 137404109 | $22K | 0.03 | 2,707 | EC | US |
| Zai Lab Ltd. | 98887Q104 | $22K | 0.03 | 1,269 | EC | KY |
| Design Therapeutics, Inc. | 25056L103 | $22K | 0.03 | 2,105 | EC | US |
| Tectonic Therapeutic, Inc. | 878972108 | $22K | 0.03 | 693 | EC | US |
| Ironwood Pharmaceuticals, Inc. | 46333X108 | $22K | 0.03 | 6,028 | EC | US |
| Arvinas, Inc. | 04335A105 | $21K | 0.03 | 2,363 | EC | US |
| Solid Biosciences, Inc. | 83422E204 | $21K | 0.03 | 2,880 | EC | US |
Page 4
of 6
Sector breakdown
Healthcare
64.1%
Other/Unmapped
35.9%
Institutional owners (13F) 22 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $785,973 | 21.94% | 7,802 | Shares | June 30, 2026 |
| Capital Investment Advisors, LLC | $599,013 | 16.72% | 5,946 | Shares | June 30, 2026 |
| Kaizen Financial Strategies | $535,554 | 14.95% | 5,315 | Shares | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $413,034 | 11.53% | 4,100 | Call option | June 30, 2026 |
| Palumbo Wealth Management LLC | $402,960 | 11.25% | 4,000 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $302,220 | 8.44% | 3,000 | Call option | June 30, 2026 |
| Jump Financial, LLC | $257,189 | 7.18% | 2,553 | Shares | June 30, 2026 |
| TOTH FINANCIAL ADVISORY CORP | $102,957 | 2.87% | 1,022 | Shares | June 30, 2026 |
| FRANKLIN RESOURCES INC | $70,115 | 1.96% | 696 | Shares | June 30, 2026 |
| PNC Financial Services Group, Inc. | $50,370 | 1.41% | 500 | Shares | June 30, 2026 |
| Ashton Thomas Private Wealth, LLC | $37,576 | 1.05% | 373 | Shares | June 30, 2026 |
| Truvestments Capital LLC | $12,593 | 0.35% | 125 | Shares | June 30, 2026 |
| Axiom Investment Management LLC | $5,037 | 0.14% | 50 | Shares | June 30, 2026 |
| Qube Research & Technologies Ltd | $4,936 | 0.14% | 49 | Shares | June 30, 2026 |
| SIMPLEX TRADING, LLC | $1,309 | 0.04% | 13 | Shares | June 30, 2026 |
| CHASE INVESTMENT COUNSEL CORP | $241 | 0.01% | 2,400 | Shares | June 30, 2026 |
| Rockefeller Capital Management L.P. | $201 | 0.01% | 2 | Shares | June 30, 2026 |
| MORGAN STANLEY | $131 | 0.00% | 1 | Shares | June 30, 2026 |
| UBS Group AG | $101 | 0.00% | 1 | Shares | June 30, 2026 |
| WELLS FARGO & COMPANY/MN | $65 | 0.00% | 1 | Shares | June 30, 2026 |
| Harel Insurance Investments & Financial Services Ltd. | $20 | 0.00% | 198 | Shares | June 30, 2026 |
| ROYAL BANK OF CANADA | $0 | 0.00% | 1 | Shares | June 30, 2026 |
Peer funds
More from this issuer
Similar by size
| Fund | AUM |
|---|---|
| AMUU Direxion Shares ETF Trust | $74.2M |
| DTEC ALPS ETF Trust | $74.4M |
| ENZL iShares Trust | $74.5M |
| DIG ProShares Trust | $74.6M |
| XOCT First Trust Exchange-Traded Fun… | $74.9M |
| ITDE iShares Trust | $73.3M |
| EIRL iShares Trust | $72.8M |
| FDIV EA Series Trust | $72.7M |
| DBEZ DBX ETF Trust | $72.7M |
| ITDB iShares Trust | $72.6M |